BRCA2 and neoplasm: Tumour suppressor genes, including TP53, BRCA1 and BRCA2, typically lose their functionality through bi-allelic loss of function (LoF), primarily caused by a loss of heterozygosity (LOH) resulting from a mutation in one allele and secondary loss of the remaining wild-type allele.